Treating Liver Cirrhosis Spontaneous bacterial peritonitis and Lipopolysaccaride by Integrated Traditional Chinese and Western Medicine
Shourong Liu
Abstract
Shourong Liu
Abstract
Objective:To observe the curative effect of integrated traditional Chinese and western medicine on treating liver cirrhosis spontaneous bacterial peritonitis (SBP) and intestinalendotoxemia (IETM). Methods: 90 cases with liver cirrhosis induced by hepatitis B were randomly divided into three groups, with 30 cases in each group. The contrast group was treated by normal methods, the Bifid Triple Viable group by Bifid Triple Viable capsules on the base of routine treatment and the combination group by Bifid Triple Viable capsules and tradition Chinese medicine of Chengqiheji decoction on the base of routine treatment. The period of therapy was 3 months. The occurred ratio of SBP and change of IETM level were investigated. Results: The levels of serum IETM in the Bifid Triple Viable group and combination group were decreased (P0.05). That change in the combination group was more obviously (P0.01). The occurred ratio of SBP in the combination group was significantly reduced (P0.05) compared with that in the contrast group (P0.05). Conclusion: Bifid Triple Viable capsules combined with Chengqiheji can improve the barrier function of intestine in patients with liver cirrhosis, and effectively decrease the occurred ratio of SBP and the level of IETM.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the curative effect of integrated traditional Chinese and western medicine on treating liver cirrhosis spontaneous bacterial peritonitis (SBP) and intestinalendotoxemia (IETM). Methods: 90 cases with liver cirrhosis induced by hepatitis B were randomly divided into three groups, with 30 cases in each group. The contrast group was treated by normal methods, the Bifid Triple Viable group by Bifid Triple Viable capsules on the base of routine treatment and the combination group by Bifid Triple Viable capsules and tradition Chinese medicine of Chengqiheji decoction on the base of routine treatment. The period of therapy was 3 months. The occurred ratio of SBP and change of IETM level were investigated. Results: The levels of serum IETM in the Bifid Triple Viable group and combination group were decreased (P0.05). That change in the combination group was more obviously (P0.01). The occurred ratio of SBP in the combination group was significantly reduced (P0.05) compared with that in the contrast group (P0.05). Conclusion: Bifid Triple Viable capsules combined with Chengqiheji can improve the barrier function of intestine in patients with liver cirrhosis, and effectively decrease the occurred ratio of SBP and the level of IETM.
Key concepts: Medicine, Spontaneous bacterial peritonitis, Cirrhosis, Gastroenterology, Decoction, Internal medicine, Peritonitis, Liver function